基本信息
浏览量:59
职业迁徙
个人简介
Dr. Rehemtulla has over 25 years of research experience in the field of oncogenic signaling in cancer as well as development and evaluation of inhibitors for these signaling pathways as anticancer therapies. He has developed technologies that enable non-invasive imaging of signaling pathways in cells as well as in mouse models of cancer. These technologies have been leveraged for the discovery of novel drugs that target oncogenic pathways and have antitumor activity. He has also utilized the ability to monitor signaling pathways in live cells to identify previously unappreciated signaling hubs that mediate the transformed phenotype.
研究兴趣
论文共 401 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Susana M Chan,Zoe Raglow,Anupama Pal, Scott D Gitlin,Maureen Legendre,Dafydd Thomas,Ranjit K Mehta,Mingjia Tan,Mukesh K Nyati,Alnawaz Rehemtulla,David M Markovitz
bioRxiv : the preprint server for biology (2024)
Yajing Liu,Wenbin Ji,Andrea Shergalis,Jiaqi Xu, Amy M. Delaney, Andrew Calcaterra,Anupama Pal,Mats Ljungman,Nouri Neamati,Alnawaz Rehemtulla
crossref(2023)
Agingno. 13 (2023): 6011-6030
引用0浏览0WOS引用
0
0
Sunita Shankar,Visweswaran Ravikumar,Hanxiao Wang,Sunjong Ji, Zainab Hasan, Ziad Fehmi, Yacoub Haydin,Daniel Wahl,Arvind Rao,Alnawaz Rehemtulla,Wajd N. Al-Holou
Cancer Researchno. 7_Supplement (2023): 3909-3909
引用0浏览0引用
0
0
Visweswaran Ravikumar,Sunita Shankar,Sunjong Ji, Zuhair Mohammad Hassan, Yacoub Haydin, Dah-Luen Huang, Ziad Fehmi,Alnawaz Rehemtulla,Arvind Rao,Wajd N. Al-Holou
Neuro-oncologyno. Supplement_5 (2023): v288-v288
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn